InvestorsHub Logo
Followers 33
Posts 1620
Boards Moderated 0
Alias Born 10/06/2015

Re: misiu143 post# 222195

Thursday, 07/20/2023 12:26:03 AM

Thursday, July 20, 2023 12:26:03 AM

Post# of 232462
Love the commercials - you can essentially trade skin blemishes (embarrassing?) for serious possible life threatening "side effects."
BUT
Leronlimab rules! minimal side effects and then, short term if there are any.

If some disease, affliction, infection, condition, etc. involves CCR5, it's worth considering leronlimab as a positive moderating intervention. This stuff is scary to a lot of biotech's proposed product lines thus their little puppy (the FDA) barks and keeps nasty old leronlimab from messing up the potential profits by "holding it at bay."
But >>>
Leronlimab RULES!

IMO
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News